Short answer
QuidelOrtho Corp (QDEL) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 FY2026 results covered quarter ended June 28, 2026.
QuidelOrtho Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 FY2026 results covered quarter ended June 28, 2026
- Press release furnished as Exhibit 99.1, containing the financial results and management commentary
- Earnings conference call scheduled August 6, 2026 at 2:00 p.m. Pacific Time
- Disclosure furnished under Regulation FD, limiting Section 18 Exchange Act filing liability
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $630.9M, up 2.8% reported and 1.9% constant currency, with 6.1% growth excluding China
- Point of Care revenue $108.2M, up 16.3%, while Labs excluding China grew 9.0%
- China revenue declined 18.7%, reflecting proposed IVD pricing changes and creating a material regional headwind
- Adjusted EBITDA $129.3M, margin 20.5%, up from 17.4%; GAAP net loss $92.9M, or $1.36 per share
- 2026 guidance reduced to revenue $2.52–$2.60B, adjusted EBITDA $540–$560M, adjusted EPS $0.65–$0.90; free cash flow guidance withdrawn
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other QuidelOrtho Corp 8-K filings
Get the next QDEL 8-K as it lands
Follow QDEL for push alerts, or ask the research agent what this filing means.